Sodastream International Ltd (SODA) Reaches $52.37 After 8.00% Down Move, Pluristem Therapeutics (PSTI) Sentiment Is 0.5

June 1, 2017 - By marketbeat

The stock of Sodastream International Ltd (NASDAQ:SODA) is a huge mover today! About 252,133 shares traded. Sodastream International Ltd (NASDAQ:SODA) has risen 180.89% since June 1, 2016 and is uptrending. It has outperformed by 164.19% the S&P500.The move comes after 6 months negative chart setup for the $3.84B company. It was reported on Jun, 1 by Barchart.com. We have $48.18 PT which if reached, will make NASDAQ:SODA worth $307.20 million less.

Pluristem Therapeutics Inc. is a developer of placenta cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company has market cap of $135.86 million. The Company’s lead indications are critical limb ischemia , recovery after surgery for femoral neck fracture and acute radiation syndrome. It currently has negative earnings. The Company’s activities are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies.

Oppenheimer & Co Inc holds 0.01% of its portfolio in Pluristem Therapeutics Inc. for 127,000 shares. Bank Of America Corp De owns 125 shares or 0% of their US portfolio. Moreover, California Public Employees Retirement System has 0% invested in the company for 181,700 shares. The Illinois-based Citadel Advisors Llc has invested 0% in the stock. Citigroup Inc, a New York-based fund reported 1,040 shares.

It is down 7.80% since June 1, 2016 and is downtrending. It has underperformed by 24.50% the S&P500.